<strong>Purpose: </strong><span><span style="font-family:""><span style="font-family:Verdana;">Verified the delivered dose distribution of lung cancer Stereotacti...<strong>Purpose: </strong><span><span style="font-family:""><span style="font-family:Verdana;">Verified the delivered dose distribution of lung cancer Stereotactic </span><span><span style="font-family:Verdana;">Body Radiotherapy (SBRT) using the cone-beam CT images. </span><b><span style="font-family:Verdana;">Methods:</span></b></span><b> </b><span style="font-family:Verdana;">Twenty </span><span style="font-family:Verdana;">lung cancer patients </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">who </span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">underwent SBRT with 100 CBCT images were</span></span><span><span style="font-family:""> <span style="font-family:Verdana;">enrolled in this study. Delivered dose distributions were recalculated on</span><span style="font-family:Verdana;"> CBCT images with </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">the </span></span><span><span style="font-family:""><span style="font-family:Verdana;">deformed and non-deformed metho</span><span style="font-family:Verdana;">d</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">s</span></span><span><span style="font-family:""><span style="font-family:Verdana;">, respectively. The </span><span style="font-family:Verdana;">planned and delivered dose distributions were compared using the</span><span style="font-family:Verdana;"> dose-volume histograms. </span><b><span style="font-family:Verdana;">Results: </span></b><span style="font-family:Verdana;">The delivered target coverage (V100) per patient inside target volume deviated on average were 0.83% ± 0.86% and 1.38% ±</span></span></span><span><span style="font-family:""> </span></span><span><span style="font-family:""><span style="font-family:Verdana;">1.40% for Pct </span><i><span style="font-family:Verdana;">vs</span></i><span style="font-family:Verdana;">. Pcbct and Pct </span><i><span style="font-family:Verdana;">vs</span></i><span style="font-family:Verdana;">. Pdcbct, respectively. The Conformity Index (CI) and Gradient Index (GI) showed a good agreement among the plans. For the critical organs, only minor differences were observed between the planned dose and </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">the </span></span><span><span style="font-family:""><span style="font-family:Verdana;">delivered dose. </span><b><span style="font-family:Verdana;">Conclusions: </span></b><span style="font-family:Verdana;">CBCT images were </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">a </span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">useful tool for setup and dose deliver</span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">y</span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"> verification for lung cancer patients </span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">who </span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">underwent SBRT.</span></span>展开更多
文摘<strong>Purpose: </strong><span><span style="font-family:""><span style="font-family:Verdana;">Verified the delivered dose distribution of lung cancer Stereotactic </span><span><span style="font-family:Verdana;">Body Radiotherapy (SBRT) using the cone-beam CT images. </span><b><span style="font-family:Verdana;">Methods:</span></b></span><b> </b><span style="font-family:Verdana;">Twenty </span><span style="font-family:Verdana;">lung cancer patients </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">who </span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">underwent SBRT with 100 CBCT images were</span></span><span><span style="font-family:""> <span style="font-family:Verdana;">enrolled in this study. Delivered dose distributions were recalculated on</span><span style="font-family:Verdana;"> CBCT images with </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">the </span></span><span><span style="font-family:""><span style="font-family:Verdana;">deformed and non-deformed metho</span><span style="font-family:Verdana;">d</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">s</span></span><span><span style="font-family:""><span style="font-family:Verdana;">, respectively. The </span><span style="font-family:Verdana;">planned and delivered dose distributions were compared using the</span><span style="font-family:Verdana;"> dose-volume histograms. </span><b><span style="font-family:Verdana;">Results: </span></b><span style="font-family:Verdana;">The delivered target coverage (V100) per patient inside target volume deviated on average were 0.83% ± 0.86% and 1.38% ±</span></span></span><span><span style="font-family:""> </span></span><span><span style="font-family:""><span style="font-family:Verdana;">1.40% for Pct </span><i><span style="font-family:Verdana;">vs</span></i><span style="font-family:Verdana;">. Pcbct and Pct </span><i><span style="font-family:Verdana;">vs</span></i><span style="font-family:Verdana;">. Pdcbct, respectively. The Conformity Index (CI) and Gradient Index (GI) showed a good agreement among the plans. For the critical organs, only minor differences were observed between the planned dose and </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">the </span></span><span><span style="font-family:""><span style="font-family:Verdana;">delivered dose. </span><b><span style="font-family:Verdana;">Conclusions: </span></b><span style="font-family:Verdana;">CBCT images were </span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">a </span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">useful tool for setup and dose deliver</span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">y</span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"> verification for lung cancer patients </span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">who </span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;">underwent SBRT.</span></span>